EDGAR Filing Documents for 0001193125-21-057223

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:

SEC Accession No. 0001193125-21-057223

Filing Date

2021-02-25

Accepted

2021-02-25 17:21:24

Documents

Effectiveness Date

2021-02-25

Document Format Files

Seq	Description	Document	Type	Size
1	S-3ASR	d122199ds3asr.htm	S-3ASR	475271
2	EX-4.7	d122199dex47.htm	EX-4.7	344538
3	EX-4.8	d122199dex48.htm	EX-4.8	344023
4	EX-4.9	d122199dex49.htm	EX-4.9	34876
5	EX-4.10	d122199dex410.htm	EX-4.10	34367
6	EX-5.1	d122199dex51.htm	EX-5.1	36603
7	EX-23.1	d122199dex231.htm	EX-23.1	2100
8	GRAPHIC	g122199dsp184.jpg	GRAPHIC	1994
9	GRAPHIC	g122199g0224144039513.jpg	GRAPHIC	6618
10	GRAPHIC	g122199g0224144936412.jpg	GRAPHIC	6735
11	GRAPHIC	g122199g0224155157950.jpg	GRAPHIC	6547
12	GRAPHIC	g122199g0224155158122.jpg	GRAPHIC	3866
13	GRAPHIC	g122199g0224155158278.jpg	GRAPHIC	6568
14	GRAPHIC	g122199g0224155158418.jpg	GRAPHIC	3744
	Complete submission text file	0001193125-21-057223.txt		1323556

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142

Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098

Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)